Please assess the completion status of the following clinical trial:

Trial Title: Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~1. 11-13 years of age.~2. Signed informed consent form (both parent's \& daughter's signature).~3. Good health status.~4. Able to comply with trial protocol.~5. Plans to stay at current school for duration of study.~Exclusion Criteria:~1. Prior HPV vaccination~2. Pregnant or lactating or intends to become pregnant during study period.~3. Apparent moderate or severe acute illness.~4. Clinical history of bleeding disorder such as hemophilia, thrombocytopenia, or anticoagulant therapy.~5. Clinical history of impaired immune responsiveness, whether due to use of immunosuppressive therapy, a genetic defect, HIV infection, or other causes.~6. Hypersensitivity to the active substances or to any of the excipients of the HPV vaccine, or such reactions to other vaccines received in the past.~7. Investigational drug or investigational vaccine administered during the period from 30 days before to 30 days after any dose of HPV vaccine.

- Gender: FEMALE
- Minimum Age: 11 Years
- Maximum Age: 13 Years
- Healthy Volunteers: t

Study Arms:
- 0,2,6 month vaccination schedule (Type: ACTIVE_COMPARATOR): None
- 0,3,9 month vaccination schedule (Type: ACTIVE_COMPARATOR): None
- 0,6,12 month vaccination schedule (Type: ACTIVE_COMPARATOR): None
- 0,12,24 month vaccination schedule (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).